>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

OSCR +15.2%, ZETA +14.6%, HIMS +14.2%, SYM +14%, MWA +13.6% (also appoints new CEO), EVER +10.1%, VMEO +10%, PRAA +9.2%, UBS +9.2%, RXST +9.1%, AMBC +9.1%, FN +8.6%, COHR +8.5%, UCTT +8.3%, CLDX +8%, EHTH +8%, BRBR +7.6%, OTTR +7.5%, JJSF +7.2%, TVTX +6.7%, SIM +6.5%, ATSG +5.7% (to operate ten Boeing 767s for AMZN), GOGO +5.1%, COKE +5%, PINC +5%, KNF +4.9%, BAND +4.8%, AORT +4.4%, FIS +4%, USLM +3.9% (also announces 5-for-1 stock split), COTY +3.9%, PRA +3.8%, IFF +3.8%, GFS +3.6%, FWRG +3.4%, TWKS +3.2%, PLYA +2.9%, HLMN +2.9%, DKL +2.8%, LITE +2.7%, SQSP +2.7%, TBI +2.6% (also files $200 mln mixed shelf), GTN +2.4%, APLS +2.3%, RCKT +2.2%, KVUE +2.2%, SAFE +2.1%, GBDC +2%, IDYA +2%, HSIC +1.9%, KOS +1.7%, TPX +1.7%, TDG +1.4%, RYTM +1.2%, BWXT +1.1%, PRGO +1.1%

Other news:

CMPO +7.6% (declares special dividend)
ADTH +5.6% (Announces Expiration of "Go-Shop" Period Contained in Previously Announced Merger Agreement and Receipt of Acquisition Proposal)
NGNE +3% (announces initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome)
CPG +2.8% (divests non-core assets)
MRUS +2% FDA accepts priority review)
EVRI +1.4% (terminates repurchase plan)
MYRG +0.9% (new $75 mln repurchase plan)

Analyst comments: